期刊
CURRENT OPINION IN PHYSIOLOGY
卷 2, 期 -, 页码 27-35出版社
ELSEVIER
DOI: 10.1016/j.cophys.2017.12.013
关键词
-
类别
资金
- NICHD/NIH (the Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health) [R01HD082373]
- National Natural Science Foundation of China [81601131, 81501123]
- Beijing Natural Science Foundation [7151010, 7172217]
- Beijing Municipal Natural Science Key Project [15G10050]
- Beijing Institute for Brain Disorders Foundation [BIBDPXM2014_014226_000016]
- Beijing Municipal Science and Technology Commission [Z161100000216133, Z161100004916169]
- Beijing key laboratory of molecular diagnosis and study on pediatric genetic diseases [BZ0317]
- National Key Research and Development Program of China [2016YFC1306201, 2016YFC0901505]
A significant number of variants/mutations in the N-methyl-D-aspartate glutamatergic receptor (NMDAR) gene family (GRIN) have been identified along with stunning advances in the technologies of next generation of whole-exome sequencing. Mutations in human GRIN genes are distributed throughout the entire gene, from amino terminal domain to C-terminal domain, in patients with various neuropsychiatric disorders, including autism spectrum disorders, epilepsy, intellectual disability, attention deficit hyperactivity disorder, and schizophrenia. Analyzing the currently available human genetic variations illustrates the genetic variation intolerance to missense mutations differs significantly among domains within the GRIN genes. Functional analyses of these mutations and their pharmacological profiles provide the first opportunity to understand the molecular mechanism and targeted therapeutic strategies for these neurological and psychiatric disorders, as well as unfold novel clues to channel function.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据